Video

Dr. Rugo on the Significance of Becoming a Giant in Cancer Care

Author(s):

Hope S. Rugo, MD, discusses the significance of becoming a Giant of Cancer Care®.

Hope S. Rugo, MD, a professor in the Department of Medicine, Hematology/Oncology, and director of Breast Oncology and Clinical Trials Education at University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, discusses the significance of becoming a Giant of Cancer Care®.

It is an honor to be recognized as a Giant in Cancer Care® in Education and to join other esteemed physicians who have held the title in education, breast cancer, and other malignancies, Rugo says. The 2020 award ceremony was held virtually for the first time, Rugo adds, and several moving speeches were delivered throughout the night.

Attendees were afforded the opportunity to hear about all the contributions that their colleagues are making in the field of oncology, and all these advances are benefitting patients around the world, Rugo adds.

Rugo will serve as chair of the the steering committee for the 2021 Giants in Cancer Care® ceremony.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC
Video

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Jun 6th 2025 - Jul 12th 2025

online-activity
Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation
Video

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Jun 6th 2025 - Jul 12th 2025

online-activity
Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing
Video

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

Jun 5th 2025 - Jul 12th 2025

online-activity